pentamidine and roflumilast

pentamidine has been researched along with roflumilast in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bailey, DS; Balasubramaniam, E; Blaazer, AR; Brown, DG; Custers, H; de Esch, IJP; de Graaf, C; de Heuvel, E; de Koning, HP; Edink, E; Jansen, C; Kalejaiye, TD; Leurs, R; Maes, L; Matheeussen, A; Mooij, WJ; Munday, JC; Orrling, KM; Siderius, M; Sijm, M; Singh, AK; Sterk, GJ; Tagoe, DNA; Tenor, H; van den Bergh, T; Veerman, JJN; Wijtmans, M	1

Other Studies

1 other study(ies) available for pentamidine and roflumilast

Article	Year
Targeting a Subpocket in Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1) Enables the Structure-Based Discovery of Selective Inhibitors with Trypanocidal Activity. Journal of medicinal chemistry, 2018, 05-10, Volume: 61, Issue:9 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Amides; Catalytic Domain; Inhibitory Concentration 50; Models, Molecular; Molecular Targeted Therapy; Phosphodiesterase Inhibitors; Protozoan Proteins; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei	2018

Article

Year

Targeting a Subpocket in Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1) Enables the Structure-Based Discovery of Selective Inhibitors with Trypanocidal Activity.

Journal of medicinal chemistry, 2018, 05-10, Volume: 61, Issue:9

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Amides; Catalytic Domain; Inhibitory Concentration 50; Models, Molecular; Molecular Targeted Therapy; Phosphodiesterase Inhibitors; Protozoan Proteins; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei

2018